Search

Your search keyword '"Innocent G"' showing total 258 results

Search Constraints

Start Over You searched for: Author "Innocent G" Remove constraint Author: "Innocent G"
258 results on '"Innocent G"'

Search Results

1. A 'Bundle of Care' to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

2. Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm

3. A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients

4. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

5. Ethnic Diversity and Warfarin Pharmacogenomics

6. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

7. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

8. Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry

9. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

10. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

11. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

12. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

13. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

14. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

15. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

16. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

17. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

18. 47. Addressing barriers to sustainable control of gastro-intestinal nematodes in sheep: Exploring novel control strategies using individual-based mathematical modelling

20. Genetic Determinants of Thiazide‐Induced Hyperuricemia, Hyperglycemia, and Urinary Electrolyte Disturbances – A Genome‐Wide Evaluation of the UK Biobank.

22. A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

23. Drug–Drug–Gene Interactions in Cardiovascular Medicine

25. A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study (Preprint)

26. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

27. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

28. A 'bundle of care' to improve anticoagulation control in patients receiving warfarin in Uganda and South Africa: Protocol for an Implementation Study (Preprint)

29. Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm

30. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

31. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

32. Drug–Drug–Gene Interactions in Cardiovascular Medicine

33. A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients

35. Ethnic Diversity and Warfarin Pharmacogenomics

37. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

38. Developing and Validating a Clinical Warfarin Dose‐Initiation Model for Black‐African Patients in South Africa and Uganda

39. Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials

40. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

42. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

44. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

45. Genetic factors associated with tuberculosis-related clinical outcomes in HIV-infected Black African patients: a systematic review and meta-analysis

46. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

47. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

48. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

49. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

50. Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm

Catalog

Books, media, physical & digital resources